Physician profile
Thuan D Le
NPI 1689650145
$6,389.29
in general payments reported to CMS, 2019-2025
37 companies · $1,000 in 2025
The $1,000 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,998 · 2020: $483 · 2021: $799 · 2022: $726 · 2023: $737 · 2024: $646 · 2025: $1,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,363 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,363.46 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,015.59 | 2019 | |
| Gilead Sciences, INC. | $770.00 | 2019-2025 | Biktarvy |
| Abbvie INC. | $681.51 | 2019-2023 | |
| Cumberland Pharmaceuticals, INC. | $414.03 | 2019-2021 | |
| Pfizer INC. | $361.03 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $346.44 | 2023-2025 | |
| Therapeuticsmd, INC. | $289.12 | 2019-2022 | |
| Evofem Biosciences, INC. | $245.10 | 2020-2022 | |
| Biogen, INC. | $243.04 | 2025 | Zurzuvae |
| Lupin INC. | $217.60 | 2019-2020 | |
| Organon LLC | $211.54 | 2021-2025 | Nexplanon |
| Coopersurgical, INC. | $175.91 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $163.93 | 2021-2025 | |
| Exeltis, USA INC. | $161.55 | 2022-2025 | Slynd, Nuvessa |
| Astellas Pharma US INC | $125.60 | 2023-2025 | Veozah |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $122.64 | 2024 | |
| Hologic Sales and Service, LLC | $122.06 | 2022-2025 | Aptima, Thinprep 2000 Processor |
| Sumitomo Pharma America, INC. | $108.21 | 2023-2025 | Myfembree |
| Agile Therapeutics, INC. | $90.20 | 2021-2024 | Twirla |
| Myovant Sciences INC. | $82.61 | 2021-2022 | |
| Dysis Medical, INC. | $57.15 | 2020 | |
| Covidien LP | $49.02 | 2019 | |
| Meditrina | $37.88 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $35.07 | 2020 | |
| Avion Pharmaceuticals | $35.05 | 2021-2022 | |
| Grt US Holding, INC. | $34.75 | 2022 | |
| Medicem INC. | $28.98 | 2021 | |
| Baxter Healthcare | $23.37 | 2025 | Perclot |
| Mimedx Group, INC. | $20.09 | 2025 | |
| Avanos Medical | $18.93 | 2024 | On-Q* Pump and Accessories |
| Exact Sciences Corporation | $18.07 | 2024 | Cologuard Collection Kit |
| Becton, Dickinson and Company | $15.79 | 2023 | Bd Onclarity |
| Minerva Surgical, INC | $15.16 | 2019 | |
| Integra Lifesciences Corporation | $14.61 | 2019 | |
| Melinta Therapeutics, LLC | $13.46 | 2019 | |
| Allergan, INC. | $13.13 | 2019 | |
| Organogenesis INC. | $11.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thuan Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.